Statement by Mr. François Hollande, President of the Republic, on the Alzheimer plan, in Paris on September 21, 2012.

France François Hollande · President of France

21 September 2012 · Alzheimer plan committee meeting, on the day dedicated to Alzheimer's disease · Paris, France

Context
Hollande addressed the French National Alzheimer's Committee in Paris on World Alzheimer's Day, September 21, 2012, to review progress and announce upcoming dependency reform.
Main themes
Alzheimer's disease, national Alzheimer's plan, caregivers and family support, aging and dependency reform, research and medical progress, dignity of patients, neurodegenerative diseases, gerontology, end-of-life care, interdisciplinary approach, memory loss, chronic psychiatric conditions
Duration
~12 min
43rd percentile
Words
1,486
43rd percentile
Sentences
75
49th percentile
Readability
49
61st percentile
Grade
11.3
36th percentile
Syntax
3.05
54th percentile
Vocabulary
2.04
16th percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 83%83%
  • Ceremonial 11%11%
  • Institutional 5%5%
  • Economic 1%1%
  • Geopolitical 0%0%
  • Technological 0%0%
  • Environmental 0%0%
  • Not in focus 0%

75 sentences in 23 paragraphs

Ladies Ministers,

Ladies and Gentlemen,

Thank you, Madam Minister. I greet the ministers present here, as well as all the personalities you each represent. I have also come to tell you that this committee is meeting here today because we want to emphasize the importance we attach first and foremost to the disease itself: 850,000 people are currently affected by this scourge; I also think of the families who are directly concerned.

I wanted us to gather here today, on this day dedicated to Alzheimer's disease, to acknowledge the role you play and this original structure you have been able to build.

Your committee has this strength of diversity. There are medical and scientific personalities here. We have high expectations in terms of research. There are professionals, those who care for, help, and support. There are representatives of families who are anxious, often in distress. There are all the associations that support patients and their families. There are home caregivers, without whom there would not be support at every moment. Therefore, I believe that what has made the strength and originality of your approach is your ability to come together.

I do not forget the administrations that are also invaluable, both at the central and territorial levels, to enable proper prevention, but also the organization of care.

Secondly, I also wanted to highlight what your committee has been able to contribute: if Alzheimer's disease is a tragedy for families and for affected individuals, at the same time, you have given hope. You have put forward avenues, responses. You have also enabled progress. On this day, many are looking to you, particularly your committee, to see what we can do, what you can still do.

I want to emphasize progress. First, there have been these homes for the autonomy and integration of Alzheimer's patients which, in the territory, not yet everywhere, provide families with an address, a door to knock on, thus, a moment, support, comfort, help. In the face of this disorder, which is not only experienced by the sick person but also affects their entire entourage, it is very important to be understood, to be guided through a painful path that is often long, very long, endless.

You have also enabled a better understanding of what we can all do together for the consideration of caregivers. I want to talk about the training of all personnel, regardless of their level of qualification, to enable them to better understand and thus better care for or better support those affected by Alzheimer's.

Finally, thanks to the mobilization of researchers, you have allowed us to better understand the mechanisms of this disease and therefore to better manage it in order to hope to cure it tomorrow.

I also wanted to emphasize what the minister said in summarizing the debate you had together today. Thanks to you, you have allowed for a better understanding of the overall issue of aging. I also think of Geneviève LAROQUE, who was for a long time the president of the national federation of gerontology, who sadly passed away a few days ago. She had long wished for this integrated approach, not to separate the sick, but rather to consider that we must work together on a coherent approach regarding the major issue of aging.

We know well that the debate will settle in society. It is already here, regarding isolation, the extreme distress of end-of-life situations, dependency, with Alzheimer's being one of the pathologies, but not the only one. There are others, what are called neurodegenerative pathologies and also a number of chronic psychiatric conditions. We must approach them in the same way as your committee has done.

We will have to return to this during the reform of dependency that the ministers present here, particularly Madam DELAUNAY, are responsible for. We are finishing the preparation of this reform, which will soon be presented, which implies that it must be funded. That is why we are keeping a certain number of resources to achieve this. But this response must not simply be a response to one case or another; it must take into account this global approach that we expect regarding the aging of the population.

What lessons can you draw that would be useful to help us with a number of decisions? I think there are two major ethical questions that you have undoubtedly reflected upon. The first is the dignity of individuals, those who are diminished, affected in what is most essential, namely memory, memories, the ability to orient themselves in time, the recognition of their loved ones, their families. So, how do we address this essential question of the dignity of the person who is so diminished, without reducing them even further through the interventions we can make with them? Every person, even sick, even without memory, has a story that is their own, which you often help to bring back to the surface, as if to give it meaning again. Every person has a life journey, a uniqueness. Therefore, it is from this unique personality that we must, that you must intervene. In this sense, the clinical approach is not enough. We touch upon the recognition of identity.

Hence the entire question of caregiver training to achieve this. But also our will, our priority to be able to keep individuals at home, that is to say, in familiar places, in everyday settings, where the situation allows.

We must all reflect on the best way to give each sick person the ability to live fully a thwarted destiny.

The second major ethical question is the treatment of what are called advance directives. Words are often chosen to avoid stating things in their rawness. That is to say, the decisions made by a person who knows they are affected by a progressive disease and who, still conscious and possessing their judgment, wishes to convey a will. How do we respect this decision, how do we analyze the moment it occurs? Is it a moment of lucidity, or is it a moment of weakness? It is not easy, I agree, to find the right way to handle these matters. But these are not just matters; they are people. And therefore, this respect for the decision regarding the most intimate choices, including end-of-life decisions, I wanted a mission to work on this. That is the mission I entrusted to Professor SICARD.

I want to make a call here for all the experiences that are yours to be shared, used for the conclusions of this mission.

I want to conclude with words of encouragement for what you have to do. The hardest part of public action is its duration; this applies to each and every one of us. There is impatience for the sick, for families, and this also applies to all citizens. We want immediate answers, immediate treatments, immediate solutions, even the establishment that can accommodate or the caregiver who can come. Therefore, what you have to do is to offer a horizon of time, to show that there is a commitment that will find its translation.

You also have, it is your responsibility and it is also ours, to mobilize all of society. It happens that Alzheimer's disease causes anxiety and worry, and sometimes everyone wonders, even at the highest level, whether we are not touched at some point by the first signs. But in reality, we now have information that well before the age of 60, people are affected by the disease. And because there is this concern, this apprehension, we must mobilize all of society. First, so that it understands what this disease means, how it manifests, so that it also ensures that everyone is warned, informed, and that we can fight together while ensuring the dignity of these individuals. Therefore, I wanted to tell you that this will of yours to act over the long term, to want to give this major issue of Alzheimer's disease a national dimension, is shared by the public authorities.

That is why the Alzheimer plan will be extended following an evaluation, because we need it. This plan will even be expanded to all neurodegenerative diseases, so that we can utilize everything that has already been initiated, accomplished, advanced, and researched in the service of patients whose disorders may at one time or another be comparable to Alzheimer's.

An action like yours needs consistency, including in the support that can be provided, but also courage and tenacity. And, receiving you here, in this place that was generally reserved for distinguished foreign guests - not all of these individuals were necessarily respectable, but it was a place where we wanted to give a certain majesty - I considered it very important that your committee could be welcomed here and feel invested with a great mission with the support of the public authorities that I represent along with the ministers who are around me.

Thank you.